Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 2401073)

Published in Circulation on October 01, 1990

Authors

P S Tsao1, N Aoki, D J Lefer, G Johnson, A M Lefer

Author Affiliations

1: Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107.

Articles citing this

Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49

Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A (1995) 1.98

In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest (1993) 1.80

Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest (1991) 1.48

Nitric oxide and cardioprotection during ischemia-reperfusion. Heart Fail Rev (2002) 1.16

Cardiac allograft vasculopathy: a review. Can J Surg (2005) 1.11

Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc Natl Acad Sci U S A (1993) 1.08

Mitochondrial fission in endothelial cells after simulated ischemia/reperfusion: role of nitric oxide and reactive oxygen species. Free Radic Biol Med (2011) 1.06

Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion. J Exp Med (1999) 1.03

Direct relationship between levels of TNF-alpha expression and endothelial dysfunction in reperfusion injury. Basic Res Cardiol (2010) 1.00

On, around, and through: neutrophil-endothelial interactions in innate immunity. Physiology (Bethesda) (2011) 0.95

Postconditioning: a mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion. Heart Fail Rev (2007) 0.94

Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest (1994) 0.92

Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide. Br J Pharmacol (1995) 0.91

Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Res Cardiol (2016) 0.87

Hypoxia preconditioning attenuates bladder overdistension-induced oxidative injury by up-regulation of Bcl-2 in the rat. J Physiol (2003) 0.87

Intestinal ischemia and reperfusion impairs vasomotor functions of pulmonary vascular bed. Ann Surg (2000) 0.87

Prolongation of myocardial viability by proteasome inhibition during hypothermic organ preservation. Biochem Biophys Res Commun (2010) 0.85

Exercise Training Prevents Coronary Endothelial Dysfunction in Type 2 Diabetic Mice. Am J Biomed Sci (2011) 0.84

Reperfusion Injury: Basic Concepts and Protection Strategies. J Thromb Thrombolysis (1997) 0.84

Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist. Br J Pharmacol (1994) 0.83

Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury. Vasc Med (2012) 0.83

Cardioprotective and endothelial protective effects of [Ala-IL8]77 in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol (1991) 0.83

Caveolin as a potential drug target for cardiovascular protection. Front Physiol (2012) 0.82

Mechanisms related to the cardioprotective effects of protein kinase C epsilon (PKC epsilon) peptide activator or inhibitor in rat ischemia/reperfusion injury. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.81

Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cytotoxity. J Clin Invest (1996) 0.81

Ulex europaeus agglutinin II (UEA-II) is a novel, potent inhibitor of complement activation. Protein Sci (2001) 0.80

Glucagon effects on ischemic vasodilatation in the isolated rat heart. J Biomed Biotechnol (2010) 0.80

The role of nitric oxide in cardiac surgery. Surg Today (1997) 0.79

Role of Endothelial Cells in Myocardial Ischemia-Reperfusion Injury. Vasc Dis Prev (2015) 0.79

Reperfusion Injury: Does It Exist and Does It Have Clinical Relevance? J Thromb Thrombolysis (1997) 0.78

Nitric oxide manipulation: a therapeutic target for peripheral arterial disease? Cardiol Res Pract (2012) 0.78

Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function. Heart (2005) 0.77

The role of tetrahydrobiopterin and dihydrobiopterin in ischemia/reperfusion injury when given at reperfusion. Adv Pharmacol Sci (2010) 0.77

Cardioprotective actions of oligotide, a single stranded polydeoxyribonucleotide complex, in myocardial ischaemia and reperfusion injury. Br J Pharmacol (1996) 0.75

Myocardial clearance of technetium-99m-teboroxime in reperfused injured canine myocardium. EJNMMI Res (2014) 0.75

Endothelial Dysfunction as a Trigger for Ischemia-Reperfusion Injury. J Thromb Thrombolysis (1997) 0.75

Optimal Duration of Coronary Ligation and Reperfusion for Reperfusion Injury Study in a Rat Model. Acta Cardiol Sin (2016) 0.75

Effects of repeated brief episodes of ischemia and reperfusion in isolated perfused rat hearts. Heart Vessels (1999) 0.75

Articles by these authors

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65

Blindness and visual impairment in southern Malawi. Bull World Health Organ (1986) 6.07

An exploration of the sequence of a 2.9-Mb region of the genome of Drosophila melanogaster: the Adh region. Genetics (1999) 5.87

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med (2000) 5.72

Increased costs and rates of use in the California workers' compensation system as a result of self-referral by physicians. N Engl J Med (1992) 4.65

The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med (1989) 4.41

HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene (2012) 4.30

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J (2000) 4.09

Spin warp NMR imaging and applications to human whole-body imaging. Phys Med Biol (1980) 4.05

Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci U S A (1993) 3.66

HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int (1994) 3.60

Observations of intergranular stress corrosion cracking in a grain-mapped polycrystal. Science (2008) 3.53

ISOLATION OF TRICHOMONAS VAGINALIS WITH PENICILLIN. Science (1945) 3.45

The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain (1987) 3.15

Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol (1995) 2.87

The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell (1997) 2.57

Fat suppression in MR imaging: techniques and pitfalls. Radiographics (1999) 2.56

Sleep patterns and total mortality: a 12-year follow-up study in Japan. J Epidemiol (2000) 2.49

Three-dimensional grain mapping by x-ray diffraction contrast tomography and the use of Friedel pairs in diffraction data analysis. Rev Sci Instrum (2009) 2.49

AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem J (1998) 2.45

Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost (2006) 2.40

The spectrum of renal disease in Laurence-Moon-Biedl syndrome. N Engl J Med (1988) 2.36

Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med (2001) 2.34

The Columbia University single-ion microbeam. Radiat Res (2001) 2.31

Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain (1988) 2.29

Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology (1999) 2.26

Blindness in the developing world. Br J Ophthalmol (1993) 2.26

Causes of suppurative keratitis in Ghana. Br J Ophthalmol (1995) 2.17

Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol (1999) 2.13

Length distribution of CDRH3 in antibodies. Proteins (1993) 2.12

Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation (1995) 2.08

Relation of Chlorogenic Acid to Scab Resistance in Potatoes. Science (1952) 2.08

Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J Biol Chem (1976) 2.07

Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology (1994) 2.07

A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) (1975) 2.01

The balance between isoforms of the prickle LIM domain protein is critical for planar polarity in Drosophila imaginal discs. Genes Dev (1999) 1.98

Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A (1995) 1.98

Infantile acute subdural hematoma. Clinical analysis of 26 cases. J Neurosurg (1984) 1.96

Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. J Card Fail (1999) 1.96

Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol (1987) 1.93

The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res (1996) 1.87

Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. AJNR Am J Neuroradiol (2006) 1.87

Implantable transvenous cardioverter-defibrillators. Circulation (1993) 1.87

Changes in the structure of wages in the 1980's: an evaluation of alternative explanations. Am Econ Rev (1992) 1.84

In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest (1993) 1.80

Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. J Clin Invest (1978) 1.79

White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res (2001) 1.76

The transcondylar approach to extradural nonneoplastic lesions of the craniovertebral junction. J Neurosurg (1996) 1.74

Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis (2001) 1.72

Three-dimensional spectral-spatial EPR imaging of free radicals in the heart: a technique for imaging tissue metabolism and oxygenation. Proc Natl Acad Sci U S A (1994) 1.70

A test of significance for geographic clusters of disease. Int J Epidemiol (1979) 1.68

Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res (1993) 1.63

Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science (1978) 1.62

Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation (1999) 1.62

Acupuncture treatment of patients with radiation-induced xerostomia. Eur J Cancer B Oral Oncol (1996) 1.61

Mosquito surveillance and polymerase chain reaction detection of West Nile virus, New York State. Emerg Infect Dis (2001) 1.60

Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest (1980) 1.58

Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol (2007) 1.57

Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. Circulation (1980) 1.56

Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J (1991) 1.55

Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption. Gastroenterology (1974) 1.54

Monitoring serum theophylline levels. Clin Pharmacokinet (1978) 1.54

Hemodynamic changes with cirrhosis of the liver: control of arteriovenous shunts during operation for esophageal varices. Ann Surg (1966) 1.53

Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J (1992) 1.53

Strategies for syphilis prevention: findings from surveys in a high-incidence area. Sex Transm Dis (2000) 1.52

Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A (1980) 1.52

Mediation of cardioprotection by transforming growth factor-beta. Science (1990) 1.52

Chronic anxiety treated by feedback-induced muscle relaxation. A pilot study. Arch Gen Psychiatry (1973) 1.51

Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem (1994) 1.50

Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J (2001) 1.49

Structure of the bacteriophage lambda cohesive end site: location of the sites of terminase binding (cosB) and nicking (cosN). Gene (1983) 1.48

Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest (1991) 1.48

Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol (1979) 1.47

Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. Proc Natl Acad Sci U S A (1979) 1.47

Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology (1988) 1.46

Central venous access in morbidly obese patients. Anesth Analg (2001) 1.45

Cardiac metastasis of lung cancer. A study of metastatic pathways and clinical manifestations. Cancer (1992) 1.44

Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol (1993) 1.44

Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency. J Clin Invest (1979) 1.43

Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med (2001) 1.43

Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol (2001) 1.42

Mononuclear cell-mediated enhancement of granulocyte function in man. J Immunol (1984) 1.42

Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation (1993) 1.42

A novel vascular relaxing agent, N-(6--aminohexyl)-5-chloro-1-naphthalensulfonamide which affects vascular smooth muscle actomyosin. J Pharmacol Exp Ther (1978) 1.42

Cellular reactivity to Candida albicans antigen. N Engl J Med (1966) 1.41

Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation (1993) 1.41

Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat. Circ Res (1974) 1.40

Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation (1992) 1.40

JEM spotlight: Environmental monitoring of airborne nanoparticles. J Environ Monit (2009) 1.40

Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler Thromb Vasc Biol (1999) 1.39

Emissions from a vehicle fitted to operate on either petrol or compressed natural gas. Sci Total Environ (2004) 1.38

Comparative analysis of hematopoietic growth factors released by stromal cells from normal donors or transplanted patients. Blood (1990) 1.38

Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. Proc Natl Acad Sci U S A (1997) 1.38

Communicating triventricular hydrocephalus and its treatment with a lumboperitoneal shunt. Neurosurgery (1985) 1.37

Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: a caution in data interpretation. Cytometry A (2003) 1.37

Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol (1990) 1.37